Published in Lancet on December 01, 1979
History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40
Chemoprophylaxis of malaria in Africa: the spent "magic bullet". Br Med J (Clin Res Ed) (1982) 1.75
Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia. Br Med J (Clin Res Ed) (1983) 1.74
The changing limits and incidence of malaria in Africa: 1939-2009. Adv Parasitol (2012) 1.72
Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 1. Results of in vivo and in vitro studies and of an ophthalmological survey. Bull World Health Organ (1982) 1.56
DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet (1986) 1.55
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
Chloroquine-resistant falciparum malaria imported into the Netherlands. Bull World Health Organ (1985) 1.41
Medical preparation for travel in Africa. J Natl Med Assoc (1982) 1.39
Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bull World Health Organ (1980) 1.29
Medicinal plants useful for malaria therapy in Okeigbo, Ondo State, Southwest Nigeria. Afr J Tradit Complement Altern Med (2006) 1.25
Chloroquine susceptibility of Plasmodium falciparum in Haiti. Bull World Health Organ (1983) 1.24
Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar J (2014) 1.02
Chloroquine-resistant falciparum malaria in Mauritania. Lancet (1995) 0.97
Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia. Malar J (2015) 0.95
Changing patterns of communicable disease in England and Wales. Part III--Increasing infectious diseases. Br Med J (1980) 0.92
Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt. Malar J (2012) 0.91
Efficacy of drug prophylaxis. J R Soc Med (1989) 0.88
Plasmodium falciparum drug resistance in Angola. Malar J (2016) 0.83
Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro. Antimicrob Agents Chemother (2012) 0.82
Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children. Bull World Health Organ (1990) 0.82
Identification of pyrimethamine- and chloroquine-resistant Plasmodium falciparum in Africa between 1984 and 1998: genotyping of archive blood samples. Malar J (2011) 0.80
Different patterns of pfcrt and pfmdr1 polymorphism in Plasmodium falciparum isolates from Tehama region, Yemen. PeerJ (2016) 0.75
Drug resistance in malaria: three cases and a review. Can Med Assoc J (1983) 0.75
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis (2001) 6.32
Trends in infectious diseases mortality in the United States. JAMA (1996) 5.79
Inconsistencies in coding of race and ethnicity between birth and death in US infants. A new look at infant mortality, 1983 through 1985. JAMA (1992) 5.62
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity (2001) 5.42
The effect of known risk factors on the excess mortality of black adults in the United States. JAMA (1990) 4.45
Genetic selection of a Plasmodium-refractory strain of the malaria vector Anopheles gambiae. Science (1986) 4.40
Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet (1992) 4.32
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24
Poverty and death in the United States--1973 and 1991. Epidemiology (1995) 4.01
The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc Natl Acad Sci U S A (1998) 3.93
Priorities among recommended clinical preventive services. Am J Prev Med (2001) 3.70
Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia. Lancet (1992) 3.51
Development of indicators to assess hunger. J Nutr (1990) 3.44
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity (1997) 3.43
Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 3.40
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med (1982) 3.26
Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission. Bull World Health Organ (1997) 3.20
Self-treatment of malaria in a rural area of western Kenya. Bull World Health Organ (1995) 3.03
Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. Am J Trop Med Hyg (1968) 2.89
Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology (1974) 2.87
Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol (1997) 2.84
Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya. Bull World Health Organ (1997) 2.73
Lung volume reduction surgery for emphysema. Med J Aust (1997) 2.70
Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology (2002) 2.67
Epidemic toxoplasmosis associated with infected cats. N Engl J Med (1979) 2.55
Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis (1993) 2.52
Within month variability in use of soup kitchens in New York State. p4. Am J Public Health (1988) 2.43
The indirect fluorescent antibody test for malaria. Am J Trop Med Hyg (1972) 2.37
Identification of Plasmodium vivax-like human malaria parasite. Lancet (1993) 2.37
Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am J Trop Med Hyg (1996) 2.34
Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980. Lancet (1981) 2.32
Excess deaths from nine chronic diseases in the United States, 1986. JAMA (1990) 2.25
Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci (1985) 2.21
Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 2.20
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature (1986) 2.19
Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev (1996) 2.17
Long-term malaria prophylaxis with weekly mefloquine. Lancet (1993) 2.09
Methods for priority setting among clinical preventive services. Am J Prev Med (2001) 2.05
Neurologic reactions after a therapeutic dose of mefloquine. N Engl J Med (1989) 2.03
Indirect cost of ischemic heart disease to employers. Am J Manag Care (2001) 2.03
Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology (1999) 2.02
Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg (1986) 2.01
Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis (2001) 1.94
Combating severe malaria in African children. Bull World Health Organ (1988) 1.94
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92
Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen. JAMA (1991) 1.90
Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med (1989) 1.88
Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg (1982) 1.85
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol (2001) 1.78
An epidemiologic study of the benefits and risks of running. JAMA (1982) 1.76
Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg (2001) 1.75
Varying virulence in rabbits infected with different filamentous types of Histoplasma capsulatum. J Bacteriol (1968) 1.73
Co-trimoxazole for childhood febrile illness in malaria-endemic regions. Lancet (1991) 1.72
Imported Plasmodium falciparum malaria in American travelers to Africa. Implications for prevention strategies. JAMA (1991) 1.70
In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age. Am J Trop Med Hyg (1986) 1.65
Malaria sporozoite penetration. A new approach by double staining. J Immunol Methods (1988) 1.65
The effectiveness of insecticide-impregnated bed nets in reducing cases of malaria infection: a meta-analysis of published results. Am J Trop Med Hyg (1995) 1.65
Studies on the transmission of simian malarias. II. Transmission of the H strain of Plasmodium knowlesi by Anopheles balabacensis balabacensis. J Parasitol (1967) 1.63
Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA). J Immunol (1984) 1.63
Mosquito-transmitted malaria in New York City, 1993. Lancet (1995) 1.63
A comparison of lymphocyte migration through intestinal lymph nodes, subcutaneous lymph nodes, and chronic inflammatory sites of sheep. Gastroenterology (1980) 1.62
The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treatment of multi-resistant falciparum malaria. Am J Trop Med Hyg (1966) 1.61
CHLORAMPHENICOL (CHLOROMYCETIN) IN EXPERIMENTAL CHOLERA INFECTIONS. J Bacteriol (1949) 1.59
Geographic subdivision of the range of the malaria parasite Plasmodium vivax. Emerg Infect Dis (2001) 1.59
Plasmodium malariae blood-stage dynamics. J Parasitol (2001) 1.59
Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis (2000) 1.59
Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans. Infect Immun (1975) 1.57
Phylogenetic relationship among the malaria parasites based on small subunit rRNA gene sequences: monophyletic nature of the human malaria parasite, Plasmodium falciparum. Mol Phylogenet Evol (1996) 1.56
Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology (2001) 1.55
Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect Immun (2000) 1.54
A framework for assessing the effectiveness of disease and injury prevention. MMWR Recomm Rep (1992) 1.53
Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens. J Clin Microbiol (1999) 1.52
Acceleromyography vs. electromyography: an ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation. Acta Anaesthesiol Scand (2005) 1.52
Identification of Plasmodium vivax sporozoites in mosquitoes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1985) 1.50
Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia (1988) 1.49
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg (1999) 1.49
Poverty and death in the United States. Int J Health Serv (1996) 1.47
Fluorescent antibody studies in human malaria. IV. Cross-reactions between human and simian malaria. Am J Trop Med Hyg (1966) 1.46
Species-specific 18S rRNA gene amplification for the detection of P. falciparum and P. vivax malaria parasites. Mol Cell Probes (1995) 1.46
Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44
Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand. Lancet (1981) 1.43
Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science (1991) 1.43
The development of a surveillance system to monitor emergency food relief in New York State. Am J Public Health (1987) 1.42
Radon and lung cancer: a cost-effectiveness analysis. Am J Public Health (1999) 1.42
A case of Morgagni hernia presenting as pneumonia. J Emerg Med (1997) 1.40
Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. Am J Trop Med Hyg (1995) 1.39
ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol (2001) 1.37
Malaria in urban and rural areas of southern Ghana: a survey of parasitaemia, antibodies, and antimalarial practices. Bull World Health Organ (1984) 1.36
Pneumonic tularemia on Martha's Vineyard. N Engl J Med (1979) 1.36
Immunization of monkeys against Plasmodium cynomolgi by X-irradiated sporozoites. Nat New Biol (1972) 1.36
Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. J Clin Epidemiol (1994) 1.35
Increasing the supply of cadaveric kidneys for transplantation. Transplantation (1981) 1.35
Studies on the persistence of malarial antibody response. Am J Epidemiol (1968) 1.35